3R22 PDB NFT
Design, synthesis, and biological evaluation of pyrazolopyridine-sulfonamides as potent multiple-mitotic kinase (MMK) inhibitors (Part I)
MOLNFT AF v1 smart contract in GenesisL1 blockchain:
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
IPFS of NFT metadata:
bafybeihm6nji75b524lrzwfooph6iuhujtr2pr4i4jbdk6uxyxqc7zq6ii/metadata.json
IPFS of structure file:
bafybeiay4xciquqgku6cf37mqyy6ajlandhf6dnpzbklrhgq5kew6lk2ti/3r22.pdb
MOLNFT 3R22 research and analysis (ICN3D with VR)
FASTA sequences
>3r22_A mol:protein length:271 Serine/threonine-protein kinase 6
GPLGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS
References and links
Current molecular structure file and data about current molecular structure file and NFT token based on it with
PDBID: 3R22
TITLE: Design, synthesis, and biological evaluation of pyrazolopyridine-sulfonamides as potent multiple-mitotic kinase (MMK) inhibitors (Part I)
DOI: 10.1016/j.bmcl.2011.06.129
AUTHORS: Zhang, L., Fan, J., Chong, J.-H., Cesana, A., Tam, B., Gilson, C., Boykin, C., Wang, D., Marcotte, D., Le Brazidec, J.-Y., Aivazian, D., Piao, J., Lundgren, K., Hong, K., Vu, K., Nguyen, K.
ACCESSION DATE: 03/11/11
Obtained at RCSB PDB https://rcsb.org
RCSB Link: https://www.rcsb.org/structure/3R22